# OnCo record inflation-reduction-act (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/inflation-reduction-act/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "inflation-reduction-act" ;
  schema:name "Inflation Reduction Act 2022: Medicare drug price negotiation"@en ;
  schema:alternateName "Inflation Reduction Act"@en, "IRA drug negotiation"@en, "Medicare Drug Price Negotiation Program"@en, "Medicare negotiation"@en, "maximum fair price"@en, "orphan exclusion"@en, "ORPHAN Cures Act"@en, "pill penalty"@en, "Part D out-of-pocket cap"@en, "inflation rebates"@en ;
  schema:description "The 2022 US law that for the first time lets Medicare negotiate prices for top-selling drugs, capped what older patients pay for prescriptions at 2,000 dollars a year, and exempted drugs approved only for rare diseases, an exemption widened in 2025."@en ;
  schema:url <https://onco.cc/terms/inflation-reduction-act/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Inflation_Reduction_Act> ;
  schema:citation <https://en.wikipedia.org/wiki/Inflation_Reduction_Act>, <https://www.congress.gov/bill/117th-congress/house-bill/5376>, <https://www.cms.gov/initiatives/medicare-prescription-drug-affordability/overview/medicare-drug-price-negotiation-program> ;
  onco:tag "law", "us" ;
  onco:related <https://onco.cc/terms/hta/>, <https://onco.cc/terms/drug-price-transparency/>, <https://onco.cc/terms/financial-toxicity/>, <https://onco.cc/terms/orphan-drug-act/>, <https://onco.cc/terms/us-regulatory-exclusivity/>, <https://onco.cc/terms/hatch-waxman/>, <https://onco.cc/terms/bpcia/>, <https://onco.cc/terms/340b-program/>, <https://onco.cc/terms/medicare-ced/>, <https://onco.cc/terms/amnog/>, <https://onco.cc/terms/eu-hta-regulation/> ;
  onco:drugs <https://onco.cc/drugs/ibrutinib/>, <https://onco.cc/drugs/enzalutamide/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-drug-pricing/>, <https://onco.cc/bottlenecks/b-incentive-misalignment/> .